Yayoi Obata

Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma

M. Shigemori, Y. Arima, R. Tanaka, 2005, Clinical Cancer Research.

Detection of Amyloid β Oligomers with RNA Aptamers in AppNL-G-F/NL-G-F Mice: A Model of Arctic Alzheimer’s Disease

Takahiko Shimizu, K. Irie, Yayoi Obata, 2020, ACS omega.

An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease

Takahiko Shimizu, K. Takabe, T. Awano, 2020, The Journal of Biological Chemistry.

Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA‐A24+ HRPC patients

K. Itoh, T. Mine, Yayoi Obata, 2005, The Prostate.

Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment.

K. Itoh, T. Mine, Yayoi Obata, 2006, Oncology research.

Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.

M. Sata, H. Yamana, K. Itoh, 2005, International journal of oncology.